Clinical Trial: Enfortumab Vedotin Schedule De-escalation in Metastatic Urothelial Carcinoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Urothelial Carcinoma
Study Type: INTERVENTIONAL
Official Title: A Pilot Trial of Enfortumab Vedotin Schedule De-escalation in Metastatic Urothelial Carcinoma
Brief Summary:
This is a non-randomized two arm open-label phase 2 pilot study in adult subjects with locally advanced or metastatic urothelial cancer.The study will investigate an alternative administration schedule of EV given as monotherapy and in combination with pembrolizumab.
Read more